CONFLUENT AND RETICULATE PAPILLOMATOSIS

This adverse event was reported 12 times

These drugs are most commonly taken by patients reporting CONFLUENT AND RETICULATE PAPILLOMATOSIS:

# Drug Count
0 CARBOPLATIN 4
1 PACLITAXEL 4
2 AMLODIPINE 1
3 ANTI ITCH 1
4 ANTI-ITCH CREAM 1
5 ANTIPRURITIC (ANTI-ITCH) 1
6 APREMILAST 1
7 AZATHIOPRINE 1
8 COOL RELIEF GEL WITH ALOE 1
9 DENOSUMAB 1
See all common drugs associated with CONFLUENT AND RETICULATE PAPILLOMATOSIS

CONFLUENT AND RETICULATE PAPILLOMATOSIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 PIMECROLIMUS 1 0.0006
1 NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE 1 0.0004
2 PACLITAXEL 4 0.0000
3 CARBOPLATIN 4 0.0000
4 RIBOCICLIB 1 0.0000
5 LETROZOLE TABLETS 1 0.0000
6 ISOTRETINOIN 1 0.0000
7 LETROZOLE 1 0.0000
8 ANTI-ITCH CREAM 1 0.0000
9 HYDROCORTISONE LOTION 1 0.0000
See all drugs enriched for association with CONFLUENT AND RETICULATE PAPILLOMATOSIS

CONFLUENT AND RETICULATE PAPILLOMATOSIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Provitamin D2 Compound [EPC] 1 0.0000
1 Interleukin-17A Antagonist [EPC] 1 0.0000
2 Microtubule Inhibitor [EPC] 4 0.0000
3 Platinum-based Drug [EPC] 4 0.0000
4 Purine Antimetabolite [EPC] 1 0.0000
5 Aromatase Inhibitor [EPC] 1 0.0000
6 Calcineurin Inhibitor Immunosuppressant [EPC] 1 0.0000
7 Phosphodiesterase 4 Inhibitor [EPC] 1 0.0000
8 Estrogen [EPC] 1 0.0000
9 RANK Ligand Inhibitor [EPC] 1 0.0000
See all drug classes enriched for association with CONFLUENT AND RETICULATE PAPILLOMATOSIS